(Q38319976)

2 September 2017

Surface loop 199-204 in blood coagulation factor IX is a cofactor-dependent site involved in macromolecular substrate interaction (English)

1 reference

2 September 2017

1 reference

Kolkman JA

1

1 reference

2 September 2017

Christophe OD

series ordinal

2

1 reference

2 September 2017

Lenting PJ

series ordinal

3

1 reference

2 September 2017

Mertens K

series ordinal

4

1 reference

2 September 2017

language of work or name

English

0 references

publication date

1 October 1999

1 reference

Journal of Biological Chemistry

2 September 2017

1 reference

2 September 2017

274

1 reference

2 September 2017

29087-29093

1 reference

2 September 2017

41

1 reference

The coagulation cascade: initiation, maintenance, and regulation

2 September 2017

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.41.29087

The molecular basis of blood coagulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.41.29087

Protein engineering of the hydrophobic domain of human factor IX.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.41.29087

X-ray structure of clotting factor IXa: active site and module structure related to Xase activity and hemophilia B

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.41.29087

Evolutionary divergence of substrate specificity within the chymotrypsin-like serine protease fold

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.41.29087

Reactivity of bovine blood coagulation factor IXa beta, factor Xa beta, and factor XIa toward fluorogenic peptides containing the activation site sequences of bovine factor IX and factor X.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.41.29087

The second Kunitz domain of human tissue factor pathway inhibitor: cloning, structure determination and interaction with factor Xa

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.41.29087

Serpin-resistant mutants of human tissue-type plasminogen activator

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.41.29087

Structure of a nonadecapeptide of the fifth EGF domain of thrombomodulin complexed with thrombin

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.41.29087

The sequence Glu1811-Lys1818 of human blood coagulation factor VIII comprises a binding site for activated factor IX.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.41.29087

Binding of human blood-coagulation Factors IXa and X to phospholipid membranes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.41.29087

Ca2+ binding to the first epidermal growth factor-like domain of human blood coagulation factor IX promotes enzyme activity and factor VIII light chain binding.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.41.29087

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.41.29087

The contribution of Ca2+ and phospholipids to the activation of human blood-coagulation Factor X by activated Factor IX

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.41.29087

Blood coagulation factor IX residues Glu78 and Arg94 provide a link between both epidermal growth factor-like domains that is crucial in the interaction with factor VIII light chain

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.41.29087

Structure of the complex formed by bovine trypsin and bovine pancreatic trypsin inhibitor. II. Crystallographic refinement at 1.9 A resolution.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.41.29087

The contributions of Ca2+, phospholipids and tissue-factor apoprotein to the activation of human blood-coagulation factor X by activated factor VII.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.41.29087

Variants of tissue-type plasminogen activator that display extraordinary resistance to inhibition by the serpin plasminogen activator inhibitor type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.41.29087

The thrombin E192Q-BPTI complex reveals gross structural rearrangements: implications for the interaction with antithrombin and thrombomodulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.41.29087

The crystal structure of the complex of blood coagulation factor VIIa with soluble tissue factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.41.29087

Regions 301-303 and 333-339 in the catalytic domain of blood coagulation factor IX are factor VIII-interactive sites involved in stimulation of enzyme activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.41.29087

21 January 2018

Identifiers

DOI

10.1074/JBC.274.41.29087

1 reference

2 September 2017

1 reference